— Know what they know.
Not Investment Advice
Also trades as: 0M3O.L (LSE)

ZGNX NASDAQ

Zogenix, Inc.
1W: +2.2% 1M: +2.1% 3M: +114.0% 1Y: +28.6% 3Y: -47.6% 5Y: +169.5%
$26.68
Last traded 2022-03-04 — delisted
NASDAQ · Healthcare · Biotechnology

Cash Flow Trends

Operating Cash Flow
-$185M -10.6% ▼
Capital Expenditures
$83K +99.3% ▲
5Y CAGR: -4.2%
Free Cash Flow
-$185M -3.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$66M -162.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
— Operating Activities —
Net Income-$127M-$124M-$420M-$209M-$227M
Depreciation & Amort.$425K$155K$1M$5M$9M
Stock-Based Comp.$6M$15M$21M$29M$35M
Change in Working Capital$11M-$3M$34M$3M-$183M
Other Non-Cash Items$33M-$867K$252M$22M$180M
Operating Cash Flow-$76M-$112M-$112M-$168M-$185M
— Investing Activities —
Capital Expenditures-$76K-$1M-$9M-$11M-$83K
Acquisitions (Net)$0$0$0$11M$0
Investment Purchases$0-$570M-$330M-$509M-$416M
Investment Sales$0$126M$592M$361M$554M
Other Investing$0$0-$180M-$16M$0
Investing Cash Flow-$76K-$445M$73M-$165M$137M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$278M$331M$32M$437M-$18M
Financing Cash Flow$278M$331M$32M$437M-$18M
Net Change in Cash$202M-$225M-$6M$105M-$66M
Cash End of Period$294M$68M$62M$167M$101M
Free Cash Flow-$76M-$113M-$121M-$179M-$185M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms